Interventional Cardiology: Peripheral Vascular Disease Therapeutic Devices
Interventional Cardiology: Peripheral Vascular Disease Therapeutic Devices
$4,750.00
This comprehensive medical market and technology report provides an overview and in-depth market analysis of devices used in the treatment of peripheral vascular disease (PVD), including peripheral arterial disease (PAD) of the lower extremities; and deep vein thrombosis (DVT) and pulmonary embolism (PE).
Publisher: Meddevicetracker
- Highlights
- Description
- Contents
Highlights
- In 2019, Meddevicetracker estimates that the global market for peripheral vascular disease (PVD) therapy devices totaled nearly $5.2bn; the market is anticipated to increase at a CAGR of 5.4% over the forecast period.
- Endovascular stent sales (including bare-metal stents and drug-eluting stents) accounted for the largest share of total product sales in 2019, with nearly half.
- The largest driver of market growth is the increasing prevalence of cardiovascular disease (CVD) as a result of the aging of the population as well as an increasing prevalence of CVD risk factors such as diabetes, high cholesterol, and obesity. Other drivers include advances in diagnostics, technological advances, growing preference for minimally invasive therapies, and increasing demand for improved healthcare in emerging markets.
Key topics covered
- an overview of PVD, including critical limb ischemia, deep vein thrombosis, and pulmonary embolism
- procedure volumes, by country/region, for percutaneous transluminal angioplasty, peripheral vascular stent implantation, peripheral atherectomy, peripheral thrombectomy, and peripheral chronic total occlusion (CTO) treatment
- related product portfolios offered by leading manufacturers
- in-depth market and competitive analyses for angioplasty catheters, vascular stents, atherectomy devices, thrombectomy devices, and CTO crossing devices
Overview
In 2019, global sales of transdermal patch products targeting the conditions covered by this analysis totaled nearly $4.9bn, and is expected to increase at a CAGR of 2.4% over the forecast period, reaching $5.5bn in 2024. The neurological disorder patches segment is expected to grow at the fastest rate, with a 3.7% CAGR over the forecast period as a result of the large market size and large potentially targetable patient caseload, while the pain management patches market is expected to experience the most dollar sales growth through 2024. Market drivers include the increasing prevalence of CVD and other associated disorders as the population ages, and improved patient compliance with patch-based pharmacology compared to oral medication. Limiters include declines in mature market segments, and strong competition from oral pharmaceuticals and generic equivalents.
The report provides the following useful information:
- epidemiology of PVD
- key statistics on selected PVD in major regions in the world
- medical device product portfolio overviews, by manufacturer
- insight into developing and potentially disruptive technologies
- in-depth market and competitive analysis.
Table of Contents
Executive Summary …………………………………………………………………….. ES-1
i. Peripheral vascular disease overview …………………………………………………………………. ES-1
ii. Global peripheral vascular disease therapeutic devices market ……………………………… ES-1
a. Market drivers and limiters…………………………………………………………………… ES-3
b. Device segment insights ………………………………………………………………………. ES-5
c. Technology trends ………………………………………………………………………………. ES-5
d. Market leaders…………………………………………………………………………………… ES-6
e. Competitive strategies…………………………………………………………………………. ES-6
f. Emerging competition ………………………………………………………………………….. ES-7
iii. Methodology………………………………………………………………………………………………… ES-7
iv. Bibliography …………………………………………………………………………………………………. ES-9
Exhibit ES-1: Peripheral vascular disease therapeutic devices, global market forecast ($m), 2019–24 ……………………………………………………………………………………………….. ES-2
Exhibit ES-2: Global peripheral vascular disease therapeutic devices market, share by country/region, 2019………………………………………………………………….. ES-3
Exhibit ES-3: Drivers and limiters of market growth…………………………………………………. ES-5
1. Peripheral Vascular Disease Overview ……………………………………………1-1
1.1 Critical limb ischemia ………………………………………………………………………………………1-2
1.2 Deep vein thrombosis/pulmonary embolism……………………………………………………….1-3
1.3 Diagnosis and treatment………………………………………………………………………………….1-5
1.4 Bibliography…………………………………………………………………………………………………..1-6
Exhibit 1-1: Estimated prevalence of peripheral artery disease, selected countries, 2017…1-2
Exhibit 1-2: Estimated incidence of deep vein thrombosis, by region, 2018……………………1-4
Exhibit 1-3: Estimated incidence of pulmonary embolism, by region, 2018…………………….1-5
2. Peripheral Vascular Disease Therapeutic Products ……………………………2-1
2.1 Angioplasty catheters………………………………………………………………………………………2-1
2.1.1 Balloon angioplasty products………………………………………………………………2-1
2.1.2 Drug-coated balloon catheter products…………………………………………………2-4
2.1.3 Cutting and scoring balloon catheter products……………………………………….2-7
2.2 Vascular stents……………………………………………………………………………………………….2-9
2.2.1 Bare-metal stents ……………………………………………………………………………2-10
2.2.2 Drug-eluting stents………………………………………………………………………….2-11
2.2.3 Bioabsorbable stents and bioresorbable vascular scaffolds…………………….2-14
2.3 Atherectomy catheters…………………………………………………………………………………..2-15
2.4 Thromboembolectomy catheters…………………………………………………………………….2-18
2.5 Chronic total occlusion therapy devices…………………………………………………………….2-22
2.6 Bibliography…………………………………………………………………………………………………2-26
Exhibit 2-1: Selected balloon angioplasty catheters for peripheral vascular disease…………2-2
Exhibit 2-2: Selected drug-coated balloons for peripheral vascular disease ……………………2-7
Exhibit 2-3: Selected cutting balloon catheters for peripheral vascular disease ………………2-8
Exhibit 2-4: Selected bare-metal stents for peripheral vascular disease……………………….2-10
Exhibit 2-5: Selected drug-eluting stents for peripheral vascular disease……………………..2-13
Exhibit 2-6: Selected atherectomy devices for peripheral vascular disease…………………..2-17
Exhibit 2-7: Selected thrombectomy devices for peripheral vascular disease………………..2-20
Exhibit 2-8: Selected chronic total occlusion crossing devices for peripheral vascular disease……………………………………………………………………….2-24
3. Peripheral Vascular Disease Therapeutic Devices Market…………………..3-1
3.1 Global market insights……………………………………………………………………………………..3-1
3.1.1 Market value ……………………………………………………………………………………3-2
3.1.2 Technology trends …………………………………………………………………………….3-8
3.1.3 Market drivers and limiters……………………………………………………………….3-10
3.1.4 PVD therapeutic devices overview……………………………………………………..3-13
3.1.5 Market leaders ……………………………………………………………………………….3-18
3.1.6 Competitive strategies……………………………………………………………………..3-18
3.1.7 Emerging competition………………………………………………………………………3-19
3.2 Global competitors………………………………………………………………………………………..3-20
3.2.1 Angioplasty catheters ………………………………………………………………………3-22
3.2.2 Vascular stents ……………………………………………………………………………….3-24
3.2.3 Atherectomy catheters…………………………………………………………………….3-26
3.2.4 Thrombectomy catheters………………………………………………………………….3-27
3.2.5 CTO crossing devices………………………………………………………………………..3-28
3.3 Market forecast…………………………………………………………………………………………….3-29
3.3.1 Market forecast: US …………………………………………………………………………3-29
3.3.2 Market forecast: Five major European markets…………………………………….3-43
3.3.3 Market forecast: Japan …………………………………………………………………….3-56
3.3.4 Market forecast: Rest of the world……………………………………………………..3-69
3.4 Bibliography…………………………………………………………………………………………………3-79
Exhibit 3-1: Peripheral vascular disease therapeutic devices, global market forecast ($m), 2019–24 ………………………………………………………………………………………………….3-3
Exhibit 3-2: Global peripheral vascular disease therapeutic device market, market forecast ($m), by product segment, 2019–24 ……………………………………..3-4
Exhibit 3-3: Global peripheral vascular disease therapeutic device sales, share by product segment, 2019 …………………………………………………………………3-5
Exhibit 3-4: Global peripheral vascular disease therapeutic devices market, share by country/region, 2019…………………………………………………………………….3-6
Exhibit 3-5: Global peripheral vascular disease therapeutic device sales, combined market forecast ($m), by country/region, 2019–24 ………………………….3-7
Exhibit 3-6: Market drivers and limiters………………………………………………………………….3-12
Exhibit 3-7: Estimated average selling price, selected angioplasty catheters, 2019 ………..3-14
Exhibit 3-8: Estimated average selling price, selected vascular stents, 2019 …………………3-15
Exhibit 3-9: Peripheral vascular disease therapeutic devices market, share by supplier, 2019 ……………………………………………………………………………3-22
Exhibit 3-10: Angioplasty catheters market, share by supplier, 2019 …………………………..3-24
Exhibit 3-11: Vascular stents market, share by supplier, 2019 ……………………………………3-25
Exhibit 3-12: Atherectomy devices market, share by supplier, 2019 ……………………………3-27
Exhibit 3-13: Thrombectomy devices market, share by supplier, 2019…………………………3-28
Exhibit 3-14: Chronic total occlusion crossing devices market, share by supplier, 2019…..3-29
Exhibit 3-15: US peripheral vascular disease therapeutic device sales, market forecast ($m), by product type, 2019–24………………………………………….3-32
Exhibit 3-16: US percutaneous transluminal angioplasty, procedure volumes forecast, 2019–24………………………………………………………..3-34
Exhibit 3-17: US percutaneous transluminal angioplasty catheter sales, market forecast ($m), 2019–24 …………………………………………………………………3-35
Exhibit 3-18: US peripheral vascular stent implantation, procedure volumes forecast, 2019–24………………………………………………………..3-36
Exhibit 3-19: US peripheral vascular stent sales, market forecast ($m), 2019–24…………..3-37
Exhibit 3-20: US peripheral atherectomy, procedure volumes forecast, 2019–24 ………….3-38
Exhibit 3-21: US peripheral atherectomy device sales, market forecast ($m), 2019–24…..3-39
Exhibit 3-22: US peripheral thrombectomy, procedure volumes forecast, 2019–24……….3-40
Exhibit 3-23: US peripheral thrombectomy sales, market forecast ($m), 2019–24 …………3-41
Exhibit 3-24: US peripheral chronic total occlusion treatment, procedure volumes forecast, 2019–24………………………………………………………..3-42
Exhibit 3-25: US peripheral chronic total occlusion crossing device sales, market forecast ($m), 2019–24 …………………………………………………………………3-43
Exhibit 3-26: 5 Euro peripheral vascular disease therapeutic device sales, market forecast ($m), by product type, 2019–24………………………………………….3-46
Exhibit 3-27: 5 Euro percutaneous transluminal angioplasty, procedure volumes forecast, 2019–24………………………………………………………..3-47
Exhibit 3-28: 5 Euro percutaneous transluminal angioplasty catheter sales, market forecast ($m), 2019–24 …………………………………………………………………3-48
Exhibit 3-29: 5 Euro peripheral vascular stent implantation, procedure volumes forecast, 2019–24………………………………………………………..3-49
Exhibit 3-30: 5 Euro peripheral vascular stent sales, market forecast ($m), 2019–24 ……..3-50
Exhibit 3-31: 5 Euro peripheral atherectomy, procedure volumes forecast, 2019–24 …….3-51
Exhibit 3-32: 5 Euro peripheral atherectomy device sales, market forecast ($m), 2019–24 …………………………………………………………………3-52
Exhibit 3-33: 5 Euro peripheral thrombectomy, procedure volumes forecast, 2019–24….3-53
Exhibit 3-34: 5 Euro peripheral thrombectomy sales, market forecast ($m), 2019–24 ……3-54
Exhibit 3-35: 5 Euro peripheral chronic total occlusion, procedure volumes forecast, 2019–24………………………………………………………..3-55
Exhibit 3-36: 5 Euro peripheral chronic total occlusion crossing device sales, market forecast ($m), 2019–24 …………………………………………………………………3-56
Exhibit 3-37: Japanese peripheral vascular disease therapeutic device sales, market forecast ($m), by product type, 2019–24………………………………………….3-59
Exhibit 3-38: Japanese percutaneous transluminal angioplasty, procedure volumes forecast, 2019–24………………………………………………………..3-60
Exhibit 3-39: Japanese percutaneous transluminal angioplasty catheter sales, market forecast ($m), 2019–24 …………………………………………………………………3-61
Exhibit 3-40: Japanese peripheral vascular stent implantation, procedure volumes forecast, 2019–24………………………………………………………..3-62
Exhibit 3-41: Japanese peripheral vascular stent sales, market forecast ($m), 2019–24….3-63
Exhibit 3-42: Japanese peripheral atherectomy, procedure volumes forecast, 2019–24 …3-64
Exhibit 3-43: Japanese peripheral atherectomy device sales, market forecast ($m), 2019–24 …………………………………………………………………3-65
Exhibit 3-44: Japanese peripheral thrombectomy, procedure volumes forecast, 2019–24………………………………………………………..3-66
Exhibit 3-45: Japanese peripheral thrombectomy sales, market forecast ($m), 2019–24 ..3-67
Exhibit 3-46: Japanese peripheral chronic total occlusion treatment, procedure volumes forecast, 2019–24………………………………………………………..3-68
Exhibit 3-47: Japanese peripheral chronic total occlusion crossing device sales, market forecast ($m), 2019–24 …………………………………………………………………3-69
Exhibit 3-48: RoW peripheral vascular disease therapeutic device sales, market forecast ($m), by product type, 2019–24………………………………………….3-71
Exhibit 3-49: RoW percutaneous transluminal angioplasty catheter sales, market forecast ($m), 2019–24 …………………………………………………………………3-74
Exhibit 3-50: RoW peripheral vascular stent sales, market forecast ($m), 2019–24………..3-75
Exhibit 3-51: RoW peripheral atherectomy device sales, market forecast ($m), 2019–24 .3-76
Exhibit 3-52: RoW peripheral thrombectomy sales, market forecast ($m), 2019–24………3-77
Exhibit 3-53: RoW peripheral chronic total occlusion crossing device sales, market forecast ($m), 2019–24 …………………………………………………………………3-78
Appendix: Company Listing……………………………………………………………. A-1
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Anemia in Chronic Kidney Disease KOL Interview – US, East Coast 
Sign up to the